Latest news articles

Added 1 month ago Drug news

Phase III AMPOWER study of Amphora meets primary endpoint in contraception.- Evofem Biosciences.

Evofem Biosciences announced that its Phase III clinical trial of Amphora (L-lactic acid, citric acid, + potassium bitartrate) for the...

Added 1 month ago Drug news

Phase III study of Liletta for contraception published in American Journal of Obstetrics & Gynecology.- Medicines360/Allergan.

Medicines360/Allergan announced newly published data finding that Liletta (levonorgestrel releasing intrauterine system) is highly efficacious in preventing pregnancy over five...

Added 5 months ago Drug news

FDA approves Annovera first one year contraceptive.- The Population Council + TherapeuticsMD.

The Population Council, a global nonprofit research organization, announced it has received FDA approval for Annovera (segesterone acetate and ethinyl...

Search all news articles for Contraceptive and procreative management

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

EADV 2018 Highlights

EADV 2018 Highlights

EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.

CDK 4/6 inhibitors in metastatic breast cancer

CDK 4/6 inhibitors in metastatic breast cancer

The CDK 4/6 Inhibitors in Metastatic Breast Cancer Learning Zone provides insights and information for metastatic breast cancer (mBC) and CDK 4/6 signalling. This includes the burden and pathophysiology of the disease, the role of CDK 4/6 in cell proliferation and an overview of the CDK 4/6 inhibitors that have been approved for the management of mBC.

Load more


Long-acting reversible contraception

The guideline offers the best-practice advice for all women of reproductive age who may wish to regulate their fertility by using LARC methods.

Added 13 years ago

Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Clinical Practice Guideline for the diagnosis, staging, risk assessment, and treatment of different cancer types during pregnancy; obstetric care and fetal follow-up; pregnancy in cancer survivors; and fertility preservation...

Added 5 years ago

UK National Guidelines on safer sex advice

This guideline provides evidence based guidance on the content of safer sex advice and the format and delivery of brief behaviour change interventions deliverable in GUM clinics.

Added 6 years ago

Search all guidelines for Contraceptive and procreative management

Journal articles

Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low dose combined oral contraceptive.

Objectives: Safe and effective contraceptive options for obese women are becoming more important due to the obesity epidemic within the...

Added 3 years ago

Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system.

OBJECTIVE: To assess 3-year data on the efficacy and safety of a new 52-mg levonorgestrel intrauterine contraceptive (LNG20) designed for...

Added 3 years ago

The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy

Background: Oral contraception (OC) and postmenopausal hormone therapy (HT) can be used to alleviate menopausal symptoms. However, the risk of venous...

Added 6 years ago

Search all journal articles for Contraceptive and procreative management